FIELD: medicine, pharmaceutics.
SUBSTANCE: agent refers to an agent representing one of N-substituted 1,4-diazabicyclo[2.2.2.]octane derivatives of general formula (I) (compounds 1-3), wherein: wherein R=1,4-substituted but-2-ine for (1), 1,5-substituted pentane for (2), 1,4-dimethylphenyl for (3) showing antiviral activity on DNA-viruses.
EFFECT: agent can find application in medicine as an active ingredient for developing therapeutic dosage forms used for treating viral diseases.
1 cl, 7 dwg, 3 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR INACTIVATING DNA VIRUSES | 2012 |
|
RU2480478C1 |
N-SUBSTITUTED 1,4-DIAZABICYCLO-[2,2,2]-OCTANE DERIVATIVES EXHIBITING RNA-ANTIVIRAL ACTIVITY | 2008 |
|
RU2399669C2 |
AGENT HAVING ANTIBACTERIAL ACTIVITY | 2010 |
|
RU2443705C1 |
POLYCATIONIC TRIVIRON COMPOUND AND METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2527256C1 |
AGENT HAVING ANTIVIRAL ACTIVITY | 2008 |
|
RU2402563C2 |
METHOD OF TREATING POULTRY WITH POLYCATIONIC TRIVIRON COMPOUND | 2013 |
|
RU2532355C1 |
AGENT FOR INACTIVATION OF VIRUSES EXHIBITING SIMULTANEOUS RIBONUCLEASE, MEMBRANOLYTIC AND ANTIVIRAL ACTIVITIES | 2008 |
|
RU2399388C2 |
CIPROFLOXACIN DERIVATIVE WITH ANTIBACTERIAL ACTIVITY AGAINST ANTIBIOTIC-RESISTANT STRAINS OF MICROORGANISMS | 2021 |
|
RU2757741C1 |
5-(CYTOSINYL-1)-1,3-OXATHIOLANES, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2142462C1 |
SUBSTITUTED SPIRO ANDROSTENES-17, 6'[1,3,4]THIADIAZINES WITH ANTIVIRAL ACTIVITY | 2021 |
|
RU2750639C1 |
Authors
Dates
2013-07-20—Published
2012-02-29—Filed